Self-replicating rna and uses thereof
AssigneeTrustees of Boston University
InventorsJoshua Edward MCGEE, Jack Rainier KIRSCH, Eric BRESSLER, Mark W. GRINSTAFF, Wilson WONG, Lidya Yidnekachew Sertse, Kexin Li
Life of this patent
Estimating the term…
Abstract
The technology described herein is directed to compositions and methods for modifying and controlling the activity of cells by expression of proteins from self-amplifying RNA (saRNA). Also described herein are compositions and methods for modifying and controlling the activity of cells by expression of proteins from self-amplifying RNA that is substituted with chemically modified nucleotides.
Claims20
A self-amplifying RNA (saRNA) comprising from 5′ to 3′:
- (a) at least one non-structural protein derived from at least one virus;
- (b) a subgenomic promoter (SGP) derived from at least one virus;
- and
- (c) at least one cargo of interest;
- wherein the saRNA comprises at least 25% modified nucleotides, wherein the modified nucleotides are selected from the group consisting of 5-methylcytidine, 5-methyluridine, 5-hydroxymethyluridine, and 5-hydroxymethylcytidine;
- wherein the initiating nucleotide comprises an adenosine or adenosine analog;
- and
- wherein the initiating nucleotide of the saRNA is methylated at the 2′O position of the ribose (Cap1).
A self-amplifying RNA (saRNA) comprising from 5′ to 3′:
- (a) a 5′ cap;
- (b) non-structural protein 1 (nsp1), non-structural protein 2 (nsp2), non-structural protein 3 (nsp3), and/or non-structural protein 4 (nsp4), each derived from at least one virus;
- (c) a subgenomic promoter (SGP) derived from at least one virus;
- (d) a 5′ untranslated region (UTR) derived from at least one virus;
- (e) at least one cargo of interest;
- (f) a 3′ untranslated region (UTR) derived from at least one virus;
- and
- (g) a poly-A tail;
- wherein the cargo comprises a chimeric antigen receptor (CAR) comprising an extracellular domain that specifically binds to an antigen of interest.
Dependencies are inferred from the claim text.